STRASBOURG, France, Aug. 13, 2025 /PRNewswire/ — Qaelon Medical, a pioneer in real-time surgical leak detection and constant-flow insufflation technologies, today welcomed two new members to its Data Advisory Board (DAB): Shanna Cotti, industry Chief Information Officer, and Robert D. Francis, President, Medical Professional Liability, ProAssurance Corporation. Robert and Shanna join existing DAB members Professor David Jayne and Assistant Professor Amin Madani announced last month.
The multidisciplinary board will guide Qaelon’s data strategy with an initial focus on two areas:
“We are thrilled to welcome Shanna and Rob to Qaelon’s Data Advisory Board,” said Eran Shlomovitz, MD, FRCPC, FRCSC, FACS, Chief Medical Officer and Founder of Qaelon Medical. “Their deep expertise and insight will help ensure our technology is optimally deployed to save lives and reduce healthcare costs by establishing the first standardized, data-driven test methodology for surgical leak detection.”
Data-Driven Surgical Leak Detection
Qaelon’s proprietary leak detection system, the first to provide quantifiable, EMR-exportable leak assessments via a proprietary constant-flow insufflator, delivers objective insights in under 30 seconds. Validated in over 1,200 preclinical tests, it modernizes a century-old workflow, enabling surgeons to identify and address life-threatening leaks in real-time to reduce risks of sepsis, reoperation, or death.
“We’re bringing the standard for surgical leak testing into the digital age while expanding the ecosystem of the intelligent OR,” said Liam Burns, CEO of Qaelon Medical. “With guidance from our Data Advisory Board, we’re creating the first Objective Performance Indicator (OPI) for surgical leaks, which will enable AI-powered clinical decision-making support, while advancing a measurable, outcomes-focused standard of care.”
About Qaelon Medical
Qaelon Medical is redefining leak detection in surgery. Its platform is the first and only system that combines real-time, AI-powered detection with precision insufflation, creating the foundation for intraoperative surgical intelligence. Headquartered in Strasbourg, France, Qaelon is backed by industry veterans, strategic partners like Caresyntax, and a global network of clinical innovators.
For more information, visit www.qaelonmedical.com or contact yee-ying.douchamps@qaelonmedical.com.
SOURCE Qaelon Medical
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…